Stay updated on GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial

Sign up to get notified when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial record for the GX-I7 and pembrolizumab study in relapsed or refractory triple-negative breast cancer is displayed, with study design, eligibility, locations, and outcome details. The record indicates the study is completed and no longer recruiting.
    Difference
    47%
    Check dated 2026-11-09T13:45:40.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T15:42:43.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:13:45.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:41.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:48:01.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden response instead of the study details, indicating access restriction to the study record.
    Difference
    0.5%
    Check dated 2026-09-28T18:11:50.000Z thumbnail image

Stay in the know with updates to GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.